ClinicalTrials.gg

Drug

Chiglitazar clinical trials

Also written CS038 and Carfloglitazar.

studies test it
13
open now
5
in phase 3
4
first study started
2014

Keep track of what changes. Save the chiglitazar studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

13 studies that test it; most in 2022 (3)

Studies that test chiglitazar, by start year
YearStudies
20142
20211
20223
20233
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
4
No phase
4

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 7 · Other 6

Chipscreen Biosciences, Ltd. (7) · Shengjing Hospital (1) · Second Xiangya Hospital of Central South University (1) · Beijing Friendship Hospital (1) · Yufan Wang (1) · Yanbing Li (1) · Shanghai Jiao Tong University School of Medicine (1)

Often tested with

Tested in the same studies.

Empagliflozin (1) · Atorvastatin (1) · Valsartan (1)

Studies

Open first, then newest update. How each study uses chiglitazar is read from its arms, and is right about nine times in ten.

Testing it · 13

Codes

What other systems call chiglitazar · ClinicalTrials.gg INT005007

  • MeSH (NLM) C515629chiglitazarOne source NLM
  • Wikidata Q76756105chiglitazarOne source Wikidata

Also registered as carfloglitazar (UNII 8WE94VAO6U).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.